Therapeutic Area: Pulmonology
Severe Eosinophilic Asthma
We are conducting a clinical trial for adults with severe eosinophilic asthma. This study offers access to investigational Benralizumab therapy under expert medical care. Participants receive study-related care at no cost, plus compensation for time and travel, while contributing to research that may advance future asthma treatment.